» Articles » PMID: 7673432

Untreated Graves' Disease Patients Without Clinical Ophthalmopathy Demonstrate a High Frequency of Extraocular Muscle (EOM) Enlargement by Magnetic Resonance

Overview
Specialty Endocrinology
Date 1995 Sep 1
PMID 7673432
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

12 of 17, a significant frequency (71%), of untreated Graves' disease patients with no clinical ophthalmopathy showed extraocular muscle (EOM) enlargement by Magnetic Resonance Imaging (MRI). Enlargement was bilateral in 41% and unilateral in 29% in these patients. Apparent enlargements of EOM were also detected, by MRI, in all of 11 Graves' disease patients with clinical ophthalmopathy, bilateral in 73% and unilateral in 27% of patients in this group. Both group showed the inferior rectus muscle as the most frequently involved (56% and 77% respectively). In 16 patients without autoimmune thyroid disorders or ophthalmopathy who served as normal controls, only 2 of these patients (12%) demonstrated mild EOM enlargement. The severity and patterns of EOM enlargement revealed no correlation with abnormalities in serum thyroid function tests or serum thyroidal autoantibodies. In conclusion, a high frequency of Graves' disease patients without clinical eye signs or symptoms harbor EOM abnormalities, as demonstrated by MRI. This suggests that present clinical examination methods are insufficient to diagnose varying degrees of ophthalmopathy in patients with autoimmune thyroid disorders who do not initially present with clinical ophthalmopathy.

Citing Articles

Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy.

Kim C, Park J, Choi Y, Jun H, Chung J, Park T Front Endocrinol (Lausanne). 2024; 15:1420024.

PMID: 39280007 PMC: 11392736. DOI: 10.3389/fendo.2024.1420024.


Correlation between extraocular muscle enlargement and thyroid autoantibodies in thyroid eye disease.

Koizumi T, Tanaka T, Umeda K, Komiyama D, Obata H Jpn J Ophthalmol. 2024; 68(3):250-258.

PMID: 38609717 PMC: 11087308. DOI: 10.1007/s10384-024-01061-7.


Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis.

Rodriguez de Vera Gomez P, Mendez Muros M, Torres Cuadro A, Toyos Saenz de Miera F, Lopez Ruiz R, Guerrero Vazquez R J Neurol. 2023; 271(1):486-496.

PMID: 37773417 DOI: 10.1007/s00415-023-11995-6.


Computer aided volumetric assessment of orbital structures in patients with Graves' orbitopathy: correlation with serum thyroid antiperoxidase antibodies and disease activity.

Paniagua L, Bande M, Abalo-Lojo J, Gonzalez F Int Ophthalmol. 2023; 43(9):3377-3384.

PMID: 37338774 PMC: 10400667. DOI: 10.1007/s10792-023-02745-8.


Graves' Eye Disease: Clinical and Radiological Diagnosis.

Hutchings K, Fritzhand S, Esmaeli B, Koka K, Zhao J, Ahmed S Biomedicines. 2023; 11(2).

PMID: 36830848 PMC: 9953404. DOI: 10.3390/biomedicines11020312.